R
Roberto Bertollini
Researcher at Democratic Republic of the Congo Ministry of Health
Publications - 20
Citations - 473
Roberto Bertollini is an academic researcher from Democratic Republic of the Congo Ministry of Health. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 9, co-authored 20 publications receiving 241 citations.
Papers
More filters
Posted ContentDOI
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Laith J. Abu-Raddad,Hiam Chemaitelly,Houssein H. Ayoub,Zaina Al Kanaani,Abdullatif Al Khal,Einas Al Kuwari,Adeel A. Butt,Peter Coyle,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Hanan F. Abdul Rahim,Mohamed Ghaith Al Kuwari,Hamad Eid Al Romaihi,Sheikh Mohammad Al Thani,Roberto Bertollini +15 more
TL;DR: SARS-CoV-2 reinfection appears to be a rare phenomenon suggestive of a strong protective immunity against reinfections that lasts for at least a few months post primary infection.
Posted ContentDOI
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu Raddad,Laith J. Abu Raddad,Hiam Chemaitelly,Hiam Chemaitelly,Houssein H. Ayoub,Zaina Al Kanaani,Abdullatif Al Khal,Einas Al Kuwari,Adeel A. Butt,Peter Coyle,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Robert Owen,Hanan F. Abdul Rahim,Samya Al Abdulla,Mohamed Ghaith Al Kuwari,Mujeeb Chettiyam Kandy,Hatoun Saeb,Shazia Nadeem N. Ahmed,Hamad Eid Al Romaihi,Devendra Bansal,Louise Dalton,Sheikh Mohammad Al Thani,Roberto Bertollini +24 more
TL;DR: The SARS-CoV-2 epidemic in Qatar demonstrated a classic susceptible-infected-recovered SIR dynamics with a rather stable R0 of about 1.6, and the young demographic structure of the population yielded a milder disease burden and lower mortality than elsewhere.
Posted ContentDOI
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
Patrick Tang,Mohammad Rubayet Hasan,Hiam Chemaitelly,Hiam Chemaitelly,Hadi M. Yassine,Hadi M. Yassine,Fatiha M. Benslimane,Fatiha M. Benslimane,Hebah A. Al Khatib,Hebah A. Al Khatib,Sawsan AlMukdad,Sawsan AlMukdad,Peter Coyle,Peter Coyle,Peter Coyle,Houssein H. Ayoub,Zaina Al Kanaani,Einas Al Kuwari,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Riyazuddin Mohammad Shaik,Hanan F. Abdul Rahim,Gheyath K. Nasrallah,Gheyath K. Nasrallah,Mohamed Ghaith Al Kuwari,Hamad Eid Al Romaihi,Adeel A. Butt,Adeel A. Butt,Mohamed H. Al-Thani,Abdullatif Al Khal,Roberto Bertollini,Laith J. Abu-Raddad +32 more
TL;DR: In this paper, the BNT162b2 and mRNA-1273 vaccines were evaluated against the SARS-CoV-2 Delta (B.617.2) variant of concern in the population of Qatar.
Posted ContentDOI
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
Mohammad Rubayet Hasan,Mahesh K. R. Kalikiri,Faheem Mirza,Sathyavathi Sundararaju,Anju Sharma,Stephan Lorenz,Hiam Chemaitelly,Hiam Chemaitelly,Reham A. El-Kahlout,Kin Ming Tsui,Hadi M. Yassine,Peter Coyle,Peter Coyle,Abdullatif Al Khal,Roberto Bertollini,Mohamed H. Al Thani,Laith J. Abu-Raddad,Laith J. Abu-Raddad,Patrick Tang +18 more
TL;DR: In this article, the authors used RT-qPCR for real-time tracking of SARS-CoV-2 variants of concern in COVID-19 in Qatar, using 9792 nasopharyngeal PCR-positive samples collected between April-June 2021 were successfully genotyped, revealing the importation and transmission dynamics of these three variants in Qatar.
Posted ContentDOI
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
Houssein H. Ayoub,Hiam Chemaitelly,Hiam Chemaitelly,Shaheen Seedat,Shaheen Seedat,Monia Makhoul,Monia Makhoul,Zaina Al Kanaani,Abdullatif Al Khal,Einas Al Kuwari,Adeel A. Butt,Peter Coyle,Andrew Jeremijenko,Anvar Hassan Kaleeckal,Ali Nizar Latif,Riyazuddin Mohammad Shaik,Hadi M. Yassine,Hadi M. Yassine,Mohamed Ghaith Al Kuwari,Hamad Eid Al Romaihi,Mohamed H. Al-Thani,Roberto Bertollini,Laith J. Abu Raddad,Laith J. Abu Raddad +23 more
TL;DR: Use of modeling and forecasting to guide the Qatari national response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic proved to be a successful strategy, reducing the toll of the epidemic to a manageable level for the healthcare system.